AsMedic
Asthma Anti-inflammatory Medication Control
StartupAsMedic is a Haifa-based startup in the Health Tech & Life Sciences sector, established in 2005. Asthma Anti-inflammatory Medication Control. The company has raised a total of $500K across 1 funding round, currently at the A stage. Key investors include Pharmaceutical company. The company has 1-10 employees. Core technologies: Sensing.
With $500K in total funding, AsMedic is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2C business model. Product stage: Alpha. The company holds 1 patent.
- StageA
- ProductAlpha
- ModelB2C
- Employees1-10
- HQHaifa
- DistrictNorth District
- Last Round$500K
- Pharmaceutical company
What does AsMedic do?
AsMedic develops solutions to address the dynamic relationship between airway obstruction level and the correct drug dosage to treat asthma. AsMedics platform technology and concept are designed to ensure efficient and personalized drug therapy by delivering the optimal preplanned dosage into the lungs. Because the platform facilitates varied drug dosages, the patient can control the lungs deposition and bioavailability, improving therapy control and significantly decreasing the side effects of inhaled steroids.
How much funding has AsMedic raised?
AsMedic has raised $500K in total funding across 1 rounds. The company is currently at the A stage. Key investors include Pharmaceutical company.
What sector is AsMedic in?
AsMedic operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drug Delivery, Medical Devices, Medical Treatment & Therapeutics, with core technologies in Sensing. Target customers: Healthcare & Life Sciences, Healthcare, Patients.
Where is AsMedic located?
AsMedic is based in HaTichon St 14, Haifa, Israel, North District.